Skip to main content
Caplight Logo









Stellate Therapeutics Inc.

Stellate Therapeutics Inc.

Private
ParisHealthcare & Life Scienceshttps://stellate-tx.com

Last Round

VC Round

May 18, 2021

Company Overview

Stellate Therapeutics Inc. is a biotechnology company that develops small molecules produced by human gut bacteria into first-in-class personalized therapies for neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

microbiome therapeuticsgut-brain axissmall molecule therapyneurodegenerative diseaseParkinson's diseasedrug discovery platformAlzheimer's diseasevirtual biotechclinical stage biotechfirst-in-class therapygut-brain connectionbug-to-drugpreclinical biotechqueuine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stellate Therapeutics Inc. Comparables

Compare Stellate Therapeutics Inc. with similar companies based on industry and business-model similarity.

Stellate Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enterin
85%
Vertero Therapeutics
82%
Holobiome
74%

Stellate Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 18, 2021

Stellate Therapeutics Inc. Investors

Notable investors and investment history

Stellate Therapeutics Inc. investors
InvestorRounds
eureKAREVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2024

    Monthly visitors increased 252% MoM, reaching 327.

  • May 18, 2021

    Led by eureKARE

Stellate Therapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

Stellate Therapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stellate Therapeutics Inc.'s valuation, stock price, and market status.

Is Stellate Therapeutics Inc. a public or private company?

Stellate Therapeutics Inc. is a private company.

What is the current stock price of Stellate Therapeutics Inc.?

Stellate Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Stellate Therapeutics Inc. worth (valuation)?

Valuation information for Stellate Therapeutics Inc. is not publicly available.

Can I buy Stellate Therapeutics Inc. stock?

Stellate Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stellate Therapeutics Inc.'s last funding round?

Stellate Therapeutics Inc.'s most recent funding round was VC Round on May 18, 2021.

Who are the main investors in Stellate Therapeutics Inc.?

Key investors in Stellate Therapeutics Inc. include eureKARE.

Will Stellate Therapeutics Inc. IPO soon?

No public IPO plans have been announced for Stellate Therapeutics Inc..

How can I track Stellate Therapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stellate Therapeutics Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Year Founded2009
Last FundingMay 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?